Disease Overview：Hysteroscopic tubal cannulation and flushing（HTCF）
Hysteroscopic tubal cannulation and chromopertubation is a minimally invasive diagnostic and therapeutic procedure performed in reproductive medicine to evaluate and treat proximal tubal occlusion—blockage near the uterotubal junction. Under direct hysteroscopic visualization, a fine catheter is advanced through the cervical canal into the uterine cavity and gently inserted into the tubal ostium to deliver saline or dye (e.g., methylene blue or indigo carmine) under controlled pressure. Successful passage of fluid confirms tubal patency; resistance or reflux may indicate obstruction, which can often be relieved during the same procedure via mechanical recanalization. This technique is particularly indicated for infertility patients with suspected unilateral or bilateral proximal tubal factor, especially when prior HSG suggests cornual blockage but no pelvic adhesions or distal pathology are present. Compared to laparoscopy, it avoids abdominal incisions, reduces recovery time, and carries lower infection and anesthesia risks. Outcomes depend on etiology—success rates for conception post-procedure range from 20% to 45% over 12 months, with higher likelihood in cases of mucosal spasm or mild stenosis rather than fibrotic occlusion.
China offers distinct advantages for this procedure: Reproductive medicine centers in tier-1 cities (e.g., Beijing, Shanghai, Guangzhou) employ board-certified reproductive endoscopists with extensive experience in hysteroscopic microsurgery, supported by state-of-the-art integrated hysteroscopy systems (e.g., Karl Storz, Olympus ENDOEYE FLEX), real-time digital imaging, and standardized protocols aligned with ESHRE/ASRM guidelines. Over 8,000 such procedures are performed annually across accredited fertility hospitals, with published clinical data showing technical success rates exceeding 75% and cumulative live birth rates comparable to Western benchmarks. Crucially, costs remain highly competitive—typically USD $1,200–$2,000 inclusive of diagnostics, procedure, and follow-up—representing 40–60% savings versus equivalent care in the US, UK, or Germany, without compromising safety or efficacy. As your dedicated medical tourism partner, we streamline the entire journey for international patients: pre-travel eligibility assessment, direct coordination with JCI-accredited hospitals, transparent all-inclusive pricing, visa support, multilingual clinical liaison, accommodation logistics, and post-treatment teleconsultation—all designed to ensure clinical continuity, cultural comfort, and financial predictability.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Hysteroscopic Tubal Cannulation and Hydrotubation
Non-Surgical / Conservative Options
*Indicated for mild tubal stenosis (e.g., proximal occlusion <2 cm), normal ovarian reserve, no pelvic adhesions.*
- •Oral ovulation induction + timed intercourse:
- Baseline transvaginal ultrasound (Day 2–3): $32 - Mid-cycle follicular monitoring (2 sessions): $64 - Serum progesterone (Luteal phase): $12
- •Intrauterine insemination (IUI) × 3 cycles:
- Total for 3 cycles: $585–$720
Surgical / Procedural Options
*Eligibility: Confirmed proximal tubal occlusion on HSG or saline sonohysterography; BMI <32; no active pelvic infection or uncontrolled coagulopathy.*
- •Hysteroscopic tubal cannulation + hydrotubation (single-session):
- Vaginal secretion culture + sensitivity: $28 - TORCH panel (IgM/IgG): $68 - Coagulation profile + CBC: $36 - Transvaginal ultrasound (uterine cavity assessment): $32 - Procedure fee (Grade 3A hospital, including hysteroscope, guidewire, balloon catheter, saline infusion, anesthesia): - Standard case (unilateral occlusion, no intrauterine pathology): $420–$510 - Complex case (bilateral occlusion + uterine polyp resection): $630–$780 - Post-procedure antibiotics (3-day course): $15
Special / Complex Condition Management
- •Recurrent proximal occlusion after prior cannulation:
- •Combined distal + proximal obstruction:
- •Adhesions + tubal occlusion (Asherman’s + proximal block):
Quick Selection Guide
- •Age <35, unilateral occlusion, budget <$600: Opt for single-session hysteroscopic cannulation ($420–$510). Highest cost-efficiency with ~65% 6-month patency rate.
- •Age 35–39, bilateral occlusion, comorbid endometritis: Choose preoperative antibiotic optimization + complex cannulation ($630–$780). Reduces re-occlusion risk by 40%.
- •Age ≥40, AMH <1.2 ng/mL, prior IUI failure: Skip cannulation; proceed directly to IVF—cannulation adds minimal fertility benefit but delays definitive treatment.
- •Budget-constrained (<$300): Begin with I ($585–$720 total)—though lower per-cycle cost, cumulative expense exceeds cann covers partial IUI fees.
- •Severe intrauterine adhesions + tubal block: Hysteroscopic adhesiolysis + cannulation ($860–$1,040) is first-line—addressing both structural rates by 2.3× vs sequential procedures.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Hysteroscopic tubal cannulation and flushing Medical Vacation Packages
Curated transparent all-inclusive packages combining Hysteroscopic tubal cannulation and flushing treatment with China top medical destinations:
